-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
IceCure Medical (NASDAQ:ICCM) Stock Price Down 3%
IceCure Medical (NASDAQ:ICCM) Stock Price Down 3%
IceCure Medical Ltd (NASDAQ:ICCM – Get Rating) shares fell 3% during mid-day trading on Monday . The company traded as low as $1.30 and last traded at $1.30. 137,650 shares traded hands during trading, a decline of 76% from the average session volume of 566,353 shares. The stock had previously closed at $1.34.
Analyst Ratings Changes
Separately, Maxim Group began coverage on IceCure Medical in a research note on Tuesday, October 25th. They set a "buy" rating and a $3.00 target price for the company.
Get IceCure Medical alerts:IceCure Medical Trading Down 3.0 %
The company has a 50 day moving average of $1.26 and a 200 day moving average of $1.39. The company has a current ratio of 4.22, a quick ratio of 3.58 and a debt-to-equity ratio of 0.03. The firm has a market cap of $59.31 million, a price-to-earnings ratio of -2.89 and a beta of -0.22.
IceCure Medical (NASDAQ:ICCM – Get Rating) last released its earnings results on Monday, December 5th. The company reported ($0.11) earnings per share for the quarter. The firm had revenue of $0.63 million for the quarter. IceCure Medical had a negative return on equity of 77.00% and a negative net margin of 462.46%. As a group, research analysts anticipate that IceCure Medical Ltd will post -0.42 EPS for the current year.Institutional Inflows and Outflows
A hedge fund recently bought a new stake in IceCure Medical stock. JPMorgan Chase & Co. purchased a new stake in shares of IceCure Medical Ltd (NASDAQ:ICCM – Get Rating) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,240 shares of the company's stock, valued at approximately $78,000.
About IceCure Medical
(Get Rating)
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Featured Articles
- Get a free copy of the StockNews.com research report on IceCure Medical (ICCM)
- Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
- SoFi Technologies Smashes Earnings but Beware the Fed Decision
- Buying The Dip In Colgate-Palmolive
- Mullen Automotive On Hiring Spree, What Could That Mean?
- InterDigital Raises Its Earnings Guidance
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
IceCure Medical Ltd (NASDAQ:ICCM – Get Rating) shares fell 3% during mid-day trading on Monday . The company traded as low as $1.30 and last traded at $1.30. 137,650 shares traded hands during trading, a decline of 76% from the average session volume of 566,353 shares. The stock had previously closed at $1.34.
周一午盘，Icecure Medical Ltd（纳斯达克股票代码：ICCM — 获取评级）股价下跌了3％。该公司的交易价格低至1.30美元，最后一次交易价格为1.30美元。交易期间交易了137,650股，较平均交易日交易量566,353股下降了76％。该股此前收于1.34美元。
Analyst Ratings Changes
分析师评级变化
Separately, Maxim Group began coverage on IceCure Medical in a research note on Tuesday, October 25th. They set a "buy" rating and a $3.00 target price for the company.
另外，Maxim集团在10月25日星期二的一份研究报告中开始报道IceCure Medical。他们为公司设定了 “买入” 评级和3.00美元的目标价格。
IceCure Medical Trading Down 3.0 %
iCecure Medical 交易下跌 3.0
The company has a 50 day moving average of $1.26 and a 200 day moving average of $1.39. The company has a current ratio of 4.22, a quick ratio of 3.58 and a debt-to-equity ratio of 0.03. The firm has a market cap of $59.31 million, a price-to-earnings ratio of -2.89 and a beta of -0.22.
该公司的50天移动平均线为1.26美元，200天移动平均线为1.39美元。该公司的流动比率为4.22，速动比率为3.58，债务与权益比率为0.03。该公司的市值为5,931万美元，市盈率为-2.89，beta值为-0.22。
Institutional Inflows and Outflows
机构流入和流出
A hedge fund recently bought a new stake in IceCure Medical stock. JPMorgan Chase & Co. purchased a new stake in shares of IceCure Medical Ltd (NASDAQ:ICCM – Get Rating) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,240 shares of the company's stock, valued at approximately $78,000.
一家对冲基金最近购买了IceCure Medical股票的新股份。摩根大通向美国证券交易委员会（SEC）提交的最新13F表文件显示，摩根大通在第二季度购买了iCecure Medical Ltd（纳斯达克股票代码：ICCM — Get Rating）的新股份。该机构投资者购买了该公司7,240股股票，价值约78,000美元。
About IceCure Medical
关于 iceCure Med
(Get Rating)
（获取评分）
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd是一家医疗器械公司，从事用于冷冻消融（冻结）人体肿瘤的医疗器械的研究、开发和商业化。它提供ProSense系统，一种用于治疗乳腺肿瘤的冷冻消融解决方案。该公司成立于2006年，总部位于以色列凯撒利亚。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on IceCure Medical (ICCM)
- Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
- SoFi Technologies Smashes Earnings but Beware the Fed Decision
- Buying The Dip In Colgate-Palmolive
- Mullen Automotive On Hiring Spree, What Could That Mean?
- InterDigital Raises Its Earnings Guidance
- 免费获取 StockNews.com 关于 Icecure Medical (ICCM) 的研究报告的副本
- 为什么黄金现在可以成为你投资组合的闪亮补充
- SoFi Technologies 打破收益但要当心美联储
- 买入 Colgate-Palmolive 的 Dip
- Mullen Automotive 正在疯狂招聘，那可能意味着什么？
- InterDigital 上调了收益预期
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收《iceCure医学日报》的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Icecure Medical及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧